Targeting the genetic alterations of the PI3K–AKT–mTOR pathway: Its potential use in the treatment of bladder cancers

Nadine Houédé; Philippe Pourquier

doi:10.1016/j.pharmthera.2014.06.004

Journal articles

Targeting the genetic alterations of the PI3K–AKT–mTOR pathway: Its potential use in the treatment of bladder cancers

Nadine Houédé ¹ Philippe Pourquier ²

1 CHU Nîmes - Centre Hospitalier Universitaire de Nîmes

2 Signalisation et Mecanismes Moleculaires de l'Apoptose

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Complete list of metadata

https://www.hal.inserm.fr/inserm-02438837
Contributor : Philippe Pourquier <>
Submitted on : Tuesday, January 14, 2020 - 1:30:52 PM
Last modification on : Friday, June 12, 2020 - 4:58:20 PM

Targeting the genetic alterations of the PI3K–AKT–mTOR pathway: Its potential use in the treatment of bladder cancers

Links full text

Identifiers

Collections

Citation

Export

Metrics

59

Targeting the genetic alterations of the PI3K–AKT–mTOR pathway: Its potential use in the treatment of bladder cancers

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

59